At first, antigen‐presenting cells such as dendritic cells (DC) take up and process immunogenic aberrant proteins produced by genetic mutations in tumour cells (i.e. neoantigens) and present them to naive CD8+ T cells in the lymph node. This evidence concerns the gene CD8A and neoplasm.